Summary Judgment Granted in Failure-to-Warn Case
A state court granted summary judgment to a pharmaceutical manufacturer in consolidated proceedings, ruling that an alleged failure to warn was not the proximate cause of the plaintiff’s purported injury. The day before the ruling, the same court granted the same manufacturer's motion to quash and dismissed more than 140 out-of-state plaintiffs, finding they could not establish jurisdiction in the state.
$28 Million Verdict Tossed in Drug Failure-to-Warn Case
Deposed the key witness—the prescribing physician—in a drug failure-to-warn case, leading the court to toss out a $28 million jury verdict against the pharmaceutical manufacturer based on the learned intermediary doctrine.
Shook and ACLU Reach Settlement with Kansas To Allow Hep C Treatment for Medicaid Recipients
Federal Court Excludes All Plaintiffs' Experts In Second Mirena MDL
Federal Court Holds Medical Device Claims Preempted By FDCA
Shook Wins Dismissals of MDL Cases
Won dismissals of eight cases in an MDL in which the plaintiffs alleged injuries after taking a generic version of the client’s brand-name drug; the court ruled against a theory of “innovator liability,” which would hold brand-name manufacturers liable for alleged injuries caused by generic versions of the drugs made by other pharmaceutical companies.” Jennifer Stevenson took the lead on this issue and argued two motions; the court’s first order dismissed five cases and the second order dismissed three cases.